Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.

OBJECTIVE: To compare the incidence of anti-double-stranded DNA (anti-dsDNA) antibodies in rheumatoid arthritis (RA) patients receiving either single or multiple doses of a chimeric anti-tumor necrosis factor alpha (anti-TNFalpha) antibody or placebo infusions, with or without methotrexate, in open-...

Celý popis

Podrobná bibliografie
Hlavní autoři: Charles, P, Smeenk, R, De Jong, J, Feldmann, M, Maini, R
Médium: Journal article
Jazyk:English
Vydáno: 2000

Podobné jednotky